Terns Pharmaceuticals, Inc.
TERN
$6.49
-$0.04-0.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -91.75M | -90.39M | -88.85M | -88.07M | -95.90M |
| Total Depreciation and Amortization | 697.00K | 829.00K | 896.00K | 902.00K | 918.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.61M | 13.42M | 12.96M | 12.83M | 21.00M |
| Change in Net Operating Assets | 4.08M | 4.48M | 4.98M | -403.00K | -5.02M |
| Cash from Operations | -74.36M | -71.66M | -70.02M | -74.75M | -78.99M |
| Capital Expenditure | 0.00 | -13.00K | -42.00K | -86.00K | -94.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -35.14M | -18.44M | -12.37M | 129.26M | 75.20M |
| Cash from Investing | -35.14M | -18.45M | -12.41M | 129.17M | 75.11M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 164.38M | 164.46M | 164.38M | 177.63M | 14.28M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -394.00K | -394.00K | -388.00K | -75.00K | 0.00 |
| Cash from Financing | 163.99M | 164.06M | 164.00M | 177.55M | 14.28M |
| Foreign Exchange rate Adjustments | -20.00K | -33.00K | -56.00K | 268.00K | 181.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.47M | 73.92M | 81.51M | 232.24M | 10.58M |